
Sagar V. Parikh MD FRCPC
John F. Greden Professor of Depression and Clinical Neuroscience and Professor of Psychiatry, University of Michigan; Associate Director, University of MIchigan Depression Center; Medical Director, National Network of Depression Centers; Education Chair, Canadian Network for Mood and Anxiety (CANMAT); Professor of Psychiatry, University of Toronto
Join to View Full Profile
4250 Plymouth RoadU of M Psychiatry, Rachel Upjohn BuildingAnn Arbor, MI 48109
Phone+1 734-232-0241
Fax+1 734-763-2015
Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sagar V. Parikh, M.D., FRCPC is appointed as the John F. Greden Professor of Depression and Clinical Neuroscience, and Professor of Psychiatry, at the University of Michigan, Ann Arbor. He is Medical Director of the National Network of Depression Centers (USA) and Education Chair of the Canadian Network of Mood and Anxiety Treatments. He is also a Professor of Health Management and Policy in the School of Public Health at the University of Michigan, and continues as an adjunct Professor of Psychiatry at the University of Toronto, where he was on staff full- time from 1994-2015. Dr. Parikh is the author / editor of three books and over 200 peer-reviewed articles and book chapters, and co-author of all 10 editions (1997-2018) of CANMAT treatment guidelines for Depression and for Bipolar Disorder, the world’s most cited mood disorder guidelines. Current major projects include a multi-site study of Biomarkers in Major Depression, novel medication clinical trials, website and app interventions, Workplace Depression interventions, and interventional psychiatry treatments including IV Ketamine and Transcranial Magnetic Stimulation. As medical director of Mensante, he helped create a novel internet system for recognition and management of mental disorders that is commercially marketed. He serves on the Advisory Board of Aifred (apply Artificial Intelligence tools to psychiatry) and Neonmind (employing psychedelics and developing new clinical models). Dr. Parikh was awarded the Dave Davis CEPD Research Award from the University of Toronto in 2008, the R.O. Jones Award for Best Research Paper by the Canadian Psychiatric Association in 2011, and Paula Goering Collaborative Research and Knowledge Translation Award in 2018. The Michigan Depression Toolkit, a website tool that he leads, won the 2018 Bronze Digital Health Award. He was awarded the 2019 Academic Gold Award for the Psychiatric Services Achievement from the APA, and 2020 Mogens Schou Award from ISBD.
Education & Training
- Clarke Institute of Psychiatry, University of TorontoFellowship, 1992 - 1994
- University of TorontoResidency, Psychiatry, 1989 - 1992
- University of MichiganResidency, Psychiatry, 1987 - 1988
- McGill University Faculty of MedicineClass of 1984, M.D., C.M.
- Columbia UniversityBS, Bioengineering, 1976 - 1980
Certifications & Licensure
- MI State Medical License 1987 - 2026
Awards, Honors, & Recognition
- Secretary Secretary of the International Society for Affective Disorders
- Co-Head, Section of Affective Disorders World Psychiatric Association
- R.O. Jones Award for Best Research Paper Canadian Psychiatric Association, 2011
- Join now to see all
Clinical Trials
- The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People Start of enrollment: 2008 Jun 01
- Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression Start of enrollment: 2009 Oct 01
- Telephone-based Cognitive Behavioral Therapy for Bariatric Surgery Patients: A Pilot Study Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores d...Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, Victoria S Marshe, Xiaoyu Men
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2025-03-29 - Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratiq...Simone N Vigod, Benicio N Frey, Crystal T Clark, Sophie Grigoriadis, Lucy C Barker
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2025-02-12 - Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study.Benjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, Lena C Quilty, Timothy A Allen
Translational Psychiatry. 2024-10-12
Press Mentions
- Ketamine Clinics Vary Widely in Pregnancy-Related SafeguardsSeptember 3rd, 2024
- Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met Its Primary and Key Secondary Endpoints – Comparing Zuranolone 50 Mg Co-Initiated with Standard of Care Antidepressant vs. Standard of Care Co-Initiated with Placebo in People with MDDFebruary 16th, 2022
- Psilocybin May Be the Key to Resolving the Global Obesity EpidemicJuly 28th, 2021
- Join now to see all
Professional Memberships
- Royal College of Physicians and Surgeons of CanadaFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: